Correlation Between GlycoMimetics and Clearside Biomedical

Can any of the company-specific risk be diversified away by investing in both GlycoMimetics and Clearside Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlycoMimetics and Clearside Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GlycoMimetics and Clearside Biomedical, you can compare the effects of market volatilities on GlycoMimetics and Clearside Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlycoMimetics with a short position of Clearside Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlycoMimetics and Clearside Biomedical.

Diversification Opportunities for GlycoMimetics and Clearside Biomedical

-0.5

Correlation Coefficient

GlycoMimetics  Clearside Biomedical

Very good diversification

The 3 months correlation between GlycoMimetics and Clearside is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding GlycoMimetics and Clearside Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clearside Biomedical and GlycoMimetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlycoMimetics are associated (or correlated) with Clearside Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clearside Biomedical has no effect on the direction of GlycoMimetics i.e., GlycoMimetics and Clearside Biomedical go up and down completely randomly.

Pair Corralation between GlycoMimetics and Clearside Biomedical

Given the investment horizon of 90 days GlycoMimetics is expected to under-perform the Clearside Biomedical. In addition to that, GlycoMimetics is 2.34 times more volatile than Clearside Biomedical. It trades about -0.03 of its total potential returns per unit of risk. Clearside Biomedical is currently generating about 0.08 per unit of volatility. If you would invest  101.00  in Clearside Biomedical on September 2, 2024 and sell it today you would earn a total of  4.00  from holding Clearside Biomedical or generate 3.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

GlycoMimetics  vs.  Clearside Biomedical

GlycoMimetics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in GlycoMimetics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, GlycoMimetics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Clearside Biomedical

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Clearside Biomedical are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Clearside Biomedical exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with GlycoMimetics and Clearside Biomedical

The main advantage of trading using opposite GlycoMimetics and Clearside Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlycoMimetics position performs unexpectedly, Clearside Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearside Biomedical will offset losses from the drop in Clearside Biomedical's long position.

The idea behind GlycoMimetics and Clearside Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.